These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test. Job CK, Chacko CJ, Taylor PM, Daniel M, Jesudian G. Int J Lepr Other Mycobact Dis; 1976; 44(1-2):256-66. PubMed ID: 776862 [Abstract] [Full Text] [Related]
32. Infection by Mycobacterium leprae of household contacts of lepromatous leprosy patients from a post-elimination leprosy region of Colombia. Cardona-Castro NM, Restrepo-Jaramillo S, Gil de la Ossa M, Brennan PJ. Mem Inst Oswaldo Cruz; 2005 Nov; 100(7):703-7. PubMed ID: 16410954 [Abstract] [Full Text] [Related]
34. [Correlation between early (Fernandez) and late (Mitsuda) reactions in non-contact children and adolescents without manifestations of leprosy, tested with human lepromin and different concentrations of armadillo antigen in 3 double-blind trials]. Bechelli LM, Haddad N, Pagnano PM, Fregnan RC. Acta Leprol; 1982 Nov; (86-87):97-109. PubMed ID: 6816003 [Abstract] [Full Text] [Related]
35. [Epidemiological immunological studies on leprosy in Okinawa. 6. Lepromin, lymphocyte transformation, FLA-ABS and leproagglutination tests in the in-and out-patients with leprosy and the relationships among these tests and personal or family history or clinical findings of the patients]. Minagawa F, Yoshino Y, Abe M, Saito N, Ohsawa Y, Ozawa T, Saikawa K. Nihon Rai Gakkai Zasshi; 1989 Nov; 58(2):92-111. PubMed ID: 2697714 [Abstract] [Full Text] [Related]
36. BCG immunotherapy as an adjunct to chemotherapy in BL-lL patients--its effect on clinical regression, reaction severity, nerve function, lepromin conversion, bacterial/antigen clearance and 'persister' M. leprae. Shetty VP, Mistry NF, Wakade AV, Ghate SD, Capadia GD, Pai VV. Lepr Rev; 2013 Mar; 84(1):23-40. PubMed ID: 23741880 [Abstract] [Full Text] [Related]
37. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants. Reitan LJ, Closs O, Belehu A. Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003 [Abstract] [Full Text] [Related]
38. Lymphocyte transformation in lepromatous leprosy: a study of the influence of disease activity and symptom duration. Brown AE, Vithayasai V, Scollard DM, Nelson KE, Moses V, Schauf V, Makonkawkeyoon S. Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):104-10. PubMed ID: 3738597 [Abstract] [Full Text] [Related]
40. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy. Ulrich M, Smith PG, Sampson C, Zuniga M, Centeno M, Garcia V, Manrique X, Salgado A, Convit J. Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]